Secondary Cancer after Androgen Deprivation Therapy in Prostate Cancer: A Nationwide Study by Jae Heon Kim, Gi Hwan Bae, Jaehun Jung, Tae Il Noh

“…The ADT group showed lower risks of overall cancer-specific incidence for stomach, colon/rectum, liver/inflammatory bowel disease (IBD), gall bladder/extrahepatic bile duct, lung, bladder, and kidney cancers than the non-ADT group. When the duration of ADT was more than 2 years of ADT, the ADT group showed higher risk of cancer-specific incidence for brain and other CNS cancers but lower risk of cancer-specific incidence for liver/ IBD and lung cancers than the non-ADT group. …”